Close Menu

NEW YORK (GenomeWeb) – Danaher announced today a definitive agreement to purchase General Electric's Biopharma business for a cash purchase price of $21.4 billion.

Factoring tax benefits from the structure of the deal, the net purchase price is about $20 billion, Danaher said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.